BGM
Qilian International Holding Group Limited
NASDAQ: BGM · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.29
-2.33% today
Updated 2026-04-30
Market cap
$66.81M
P/E ratio
—
P/S ratio
0.24x
EPS (TTM)
$-0.29
Dividend yield
—
52W range
$0 – $17
Volume
0.3M
Qilian International Holding Group Limited (BGM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $22.54M | $50.37M | $46.10M | $50.03M | $57.10M | $64.86M | $46.47M | $25.10M |
| Revenue growth (YoY) | — | +123.5% | -8.5% | +8.5% | +14.1% | +13.6% | -28.3% | -46.0% |
| Cost of revenue | $19.16M | $42.24M | $36.42M | $42.49M | $51.46M | $58.63M | $44.72M | $20.98M |
| Gross profit | $3.38M | $8.13M | $9.68M | $7.54M | $5.64M | $6.23M | $1.75M | $4.11M |
| Gross margin | 15.0% | 16.1% | 21.0% | 15.1% | 9.9% | 9.6% | 3.8% | 16.4% |
| R&D | — | — | — | — | — | $1.22M | $568470.00 | $1.36M |
| SG&A | — | — | — | $2.73M | $3.25M | $2.15M | $2.83M | $2.72M |
| Operating income | $1.13M | $5.97M | $6.18M | $4.81M | $2.39M | $2.10M | $-2.61M | $-563771.00 |
| Operating margin | 5.0% | 11.9% | 13.4% | 9.6% | 4.2% | 3.2% | -5.6% | -2.2% |
| EBITDA | $3.38M | $7.62M | $8.35M | $7.22M | $4.15M | $3.74M | $-1.27M | $879873.00 |
| EBITDA margin | 15.0% | 15.1% | 18.1% | 14.4% | 7.3% | 5.8% | -2.7% | 3.5% |
| EBIT | $2.14M | $6.36M | $7.17M | $6.05M | $2.95M | $2.52M | $-2.42M | $-357356.00 |
| Interest expense | $282842.00 | $216187.00 | $223657.00 | $242877.00 | $57671.00 | — | — | $639511.00 |
| Income tax | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $1.41M | $5.17M | $5.33M | $5.06M | $3.15M | $1.08M | $-7.78M | $-1.44M |
| Net income growth (YoY) | — | +265.4% | +3.1% | -5.0% | -37.7% | -65.9% | -822.6% | +81.5% |
| Profit margin | 6.3% | 10.3% | 11.6% | 10.1% | 5.5% | 1.7% | -16.7% | -5.7% |